MHRA: THIS MONOCLONAL ANTIBODY IS FOR PEOPLE WITH MILD TO MODERATE COVID-19 WHO ARE AT HIGH RISK OF DEVELOPING SEVERE DISEASE.
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Mhra: This Monoclonal Antibody Is For People With Mild To Moderate Covid-19 Who Are At High Risk Of Developing Severe Disease.